CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02703467
NCT02703467N/ACompleted

Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma

Imperial College London·observational·Posted Mar 9, 2016·Updated Oct 21, 2019

In Brief

An observational study for Asthma. Completed, enrolled 70 participants across 1 site.

Detailed Summary

The purpose of this study will be to determine whether there is any role for measuring Hydrogen Sulphide (H2S) in the exhaled breath in terms of management of the patient with asthma. The investigators will recruit patients with a range of severity of asthma and health volunteers. Levels of Hydrogen Sulphide will be measured in exhaled breath and blood. Also exhaled Nitric Oxide, Spirometry and asthma symptom scores will be measured at each study visit. Participants will attend either 2 or 4 separate visits. The investigators will determine whether there is a relationship between exhaled Hydrogen Sulphide and asthma severity.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited Kingdom

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMar 9, 2016
Enrollment StartAug 1, 2015
Primary CompletionJun 30, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 10.3 years ago